RIGL icon

Rigel Pharmaceuticals
RIGL

Overview Fund Activity

133 hedge funds and large institutions have $365M invested in Rigel Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 50 increasing their positions, 32 reducing their positions, and 16 closing their positions.

Holders
133
Holders Change
-2
Holders Change %
-1.48%
% of All Funds
2.97%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
15
Increased
50
Reduced
32
Closed
16
Calls
$1.73M
Puts
$881K
Net Calls
+$848K
Net Calls Change
+$1.49M

Top Buyers

1
Goldman Sachs
1
Goldman Sachs
New York
$9.48M
2
Citadel Advisors
2
Citadel Advisors
Florida
$15.9M
3
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$3.75M
4
TA
4
Tamarack Advisers
California
$12.7M
5
UBS Group
5
UBS Group
Switzerland
$1.6M

Top Sellers

1
BC
1
Boxer Capital
California
$0
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$10.6M
3
Millennium Management
3
Millennium Management
New York
$15.8M
4
BRF
4
B. Riley Financial
California
$0
5
MWNA
5
Marshall Wace North America
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
BCA
151
Berman Capital Advisors
Georgia
$0 28 +28 New
3 4 5 6
7